Everence Capital Management’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-58,700
Closed -$143K 816
2022
Q3
$143K Hold
58,700
0.01% 691
2022
Q2
$133K Buy
58,700
+44,530
+314% +$166K 0.01% 698
2022
Q1
$95K Buy
+14,170
New +$121K 0.01% 729
2020
Q3
Sell
-24,970
Closed -$120K 762
2020
Q2
$120K Hold
24,970
0.01% 632
2020
Q1
$88K Hold
24,970
0.01% 593
2019
Q4
$264K Hold
24,970
0.04% 522
2019
Q3
$280K Buy
+24,970
New +$296K 0.05% 449

Other funds holding DBD

Everence Capital Management's DBD Position: Q4 2022 in Review

Everence Capital Management sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 58,700 shares — an estimated $143K sold.

Everence Capital Management first reported a position in DBD in Q3 2019 and held it in 7 quarters. The position peaked at $280K in Q3 2019. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Everence Capital Management reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Everence Capital Management sold 58,700 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $143K.
  • Everence Capital Management first reported a position in Diebold Nixdorf Incorporated in Q3 2019 and held it in 7 quarters.
  • Everence Capital Management's Diebold Nixdorf Incorporated position peaked at $280K in Q3 2019.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Everence Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.